A Randomized, Double-Blind Comparison of Oral Aprepitant Alone vs Oral Aprepitant and Transdermal Scopolamine for Preventing Postoperative Nausea and Vomiting.

Trial Profile

A Randomized, Double-Blind Comparison of Oral Aprepitant Alone vs Oral Aprepitant and Transdermal Scopolamine for Preventing Postoperative Nausea and Vomiting.

Completed
Phase of Trial: Phase III

Latest Information Update: 17 Jun 2014

At a glance

  • Drugs Aprepitant (Primary) ; Scopolamine
  • Indications Postoperative nausea and vomiting
  • Focus Therapeutic Use
  • Most Recent Events

    • 24 Jul 2012 Results published in the British Journal of Anaesthesia.
    • 03 Sep 2010 Actual end date (Mar 2010) added as reported by ClinicalTrials.gov.
    • 03 Sep 2010 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top